Therapeutic inhibitors of GDF15 signalling

MYPI2026004924A0Undetermined Publication Date: 2022-09-30KYMBA LIMITED +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026004924
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-03-31
Filing Date
2022-03-31
Publication Date
2022-09-30
Patent Text Reader

Abstract

This invention relates to antibodies that bind to and inhibit the activity of glial cell-derived neurotrophic factor family receptor alpha like (GFRAL) protein. The invention also relates to the GDF15-GFRAL signalling pathway as a therapeutic target for states of cachexia and conditions involving reduction in food intake and reduction in muscle and fat mass.
Need to check novelty before this filing date? Find Prior Art